Why Is Sangamo Therapeutics Moving?

Shares of Sangamo Therapeutics Inc SGMO are higher by 7.6% Monday afternoon.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

Sangamo Therapeutics shares are trading higher after the company presented data from its Phase 1/2 Alta study evaluating investigational SB-525 gene therapy in patients with severe hemophilia A over the weekend.

Photo taken from the ‘Overview’ Details tool inside Benzinga Pro.

For live updates on SGMO, log in or try Benzinga Pro today.